Progressive supranuclear palsy (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Progressive supranuclear palsy" in English language version.

refsWebsite

Global rank English rank

93nih.gov

4^th place

64doi.org

2^nd place

16worldcat.org

5^th place

13semanticscholar.org

11^th place

8^th place

3rarediseases.org

5,181^st place

3,260^th place

1who.int

195^th place

302^nd place

1wiley.com

222^nd place

297^th place

1nhs.uk

1,989^th place

1,528^th place

1springer.com

274^th place

309^th place

1omim.org

4,380^th place

4,305^th place

1elsevier.com

610^th place

704^th place

1metapress.com

8,671^st place

7,934^th place

1oup.com

485^th place

440^th place

1jamanetwork.com

2,650^th place

3,409^th place

1orpha.net

3,537^th place

7,177^th place

1web.archive.org

1^st place

1acnr.co.uk

low place

1pspawareness.com

low place

1independent.ie

315^th place

209^th place

1harvard.edu

18^th place

17^th place

1medlink.com

low place

1pspsocietycanada.ca

low place

1pspfrance.org

low place

1pspassociation.org.uk

low place

1pspaireland.ie

low place

1psp.org

low place

1hollywoodreporter.com

15^th place

16^th place

1newyorker.com

146^th place

110^th place

1washingtonpost.com

34^th place

27^th place

1straitstimes.com

543^rd place

346^th place

acnr.co.uk

"What's New in Progressive Supranuclear Palsy?" (PDF). Acnr.org. Archived from the original (PDF) on 2016-09-09. Retrieved 2017-01-08.

doi.org

Golbe LI (April 2014). "Progressive supranuclear palsy". Seminars in Neurology. 34 (2): 151–9. doi:10.1055/s-0034-1381736. PMID 24963674.
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (July 2017). "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches". The Lancet Neurology. 16 (7): 552–563. doi:10.1016/S1474-4422(17)30157-6. PMC 5802400. PMID 28653647.
Lopez G, Bayulkem K, Hallett M (October 2016). "Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants". Acta Neurologica Scandinavica. 134 (4): 242–249. doi:10.1111/ane.12546. PMC 7292631. PMID 27070344.
Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: New disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–252. doi:10.1002/mds.10699. ISSN 0885-3185. PMID 15022178.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Finger EC (April 2016). "Frontotemporal Dementias". Continuum. 22 (2 Dementia): 464–89. doi:10.1212/CON.0000000000000300. PMC 5390934. PMID 27042904.
Dunning EE, Decourt B, Zawia NH, Shill HA, Sabbagh MN (August 2024). "Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review". Neurology and Therapy. 13 (4): 975–1013. doi:10.1007/s40120-024-00614-9. ISSN 2193-8253. PMC 11263316. PMID 38743312.
Alexander RG, Macknik SL, Martinez-Conde S (2018). "Microsaccade Characteristics in Neurological and Ophthalmic Disease". Frontiers in Neurology. 9 (144): 144. doi:10.3389/fneur.2018.00144. PMC 5859063. PMID 29593642.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Armstrong MJ (March 2018). "Progressive Supranuclear Palsy: an Update". Current Neurology and Neuroscience Reports. 18 (3): 12. doi:10.1007/s11910-018-0819-5. ISSN 1528-4042. PMID 29455271.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Alster P, Madetko N, Koziorowski D, Friedman A (2020-03-10). "Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)". Frontiers in Neurology. 11: 180. doi:10.3389/fneur.2020.00180. ISSN 1664-2295. PMC 7078665. PMID 32218768.
Chunowski P, Madetko-Alster N, Alster P (2024-09-28). "Asymmetry in Atypical Parkinsonian Syndromes-A Review". Journal of Clinical Medicine. 13 (19): 5798. doi:10.3390/jcm13195798. ISSN 2077-0383. PMC 11477316. PMID 39407856.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, et al. (September 2019). "Four-repeat tauopathies". Progress in Neurobiology. 180: 101644. doi:10.1016/j.pneurobio.2019.101644. PMID 31238088.
Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW (2002). "A clinicopathological study of vascular progressive supranuclear palsy: A multi-infarct disorder presenting as progressive supranuclear palsy". Archives of Neurology. 59 (10): 1597–601. doi:10.1001/archneur.59.10.1597. PMID 12374498.
Wen Y, Zhou Y, Jiao B, Shen L (2021). "Genetics of Progressive Supranuclear Palsy: A Review". Journal of Parkinson's Disease. 11 (1): 93–105. doi:10.3233/JPD-202302. ISSN 1877-718X. PMC 7990399. PMID 33104043.
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. (April 2002). "Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy". Brain. 125 (Pt 4): 801–11. doi:10.1093/brain/awf086. PMID 11912113.
Buée L, Delacourte A (October 1999). "Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease". Brain Pathology. 9 (4): 681–93. doi:10.1111/j.1750-3639.1999.tb00550.x. PMC 8098140. PMID 10517507. S2CID 10711305.
Feany MB, Mattiace LA, Dickson DW (January 1996). "Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration". Journal of Neuropathology and Experimental Neurology. 55 (1): 53–67. doi:10.1097/00005072-199601000-00006. PMID 8558172.
Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (April 2006). "Lewy bodies in progressive supranuclear palsy represent an independent disease process". Journal of Neuropathology and Experimental Neurology. 65 (4): 387–95. doi:10.1097/01.jnen.0000218449.17073.43. PMID 16691119.
Keith-Rokosh J, Ang LC (November 2008). "Progressive supranuclear palsy: a review of co-existing neurodegeneration". The Canadian Journal of Neurological Sciences. 35 (5): 602–8. doi:10.1017/S0317167100009392. PMID 19235444.
Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, et al. (March 2015). "Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology". Movement Disorders Clinical Practice. 2 (1): 33–38. doi:10.1002/mdc3.12104. PMC 6183005. PMID 30363831.
Gearing M, Olson DA, Watts RL, Mirra SS (June 1994). "Progressive supranuclear palsy: neuropathologic and clinical heterogeneity". Neurology. 44 (6): 1015–24. doi:10.1212/wnl.44.6.1015. PMID 8208392. S2CID 20622672.
Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. (Arizona Parkinson's Disease Consortium) (May 2014). "Concomitant pathologies among a spectrum of parkinsonian disorders". Parkinsonism & Related Disorders. 20 (5): 525–9. doi:10.1016/j.parkreldis.2014.02.012. PMC 4028418. PMID 24637124.
Kertesz A, Munoz D (2004). "Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy". Dementia and Geriatric Cognitive Disorders. 17 (4): 282–6. doi:10.1159/000077155. PMID 15178937. S2CID 21017979.
Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, et al. (September 2003). "4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 106 (3): 251–60. doi:10.1007/s00401-003-0728-8. PMID 12802605. S2CID 20275104.
Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, et al. (August 2003). "Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain". Acta Neuropathologica. 106 (2): 143–9. doi:10.1007/s00401-003-0711-4. PMID 12732936. S2CID 25741692.
Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, et al. (October 1998). "Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 96 (4): 401–8. doi:10.1007/s004010050911. PMID 9797005. S2CID 7265831.
Zhu MW, Wang LN, Li XH, Gui QP (April 2004). "[Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration]" [Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration]. Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology (in Chinese). 33 (2): 125–9. doi:10.3760/j.issn:0529-5807.2004.02.008. PMID 15132848.
Wang LN, Zhu MW, Feng YQ, Wang JH (June 2006). "Pick's disease with Pick bodies combined with progressive supranuclear palsy without tuft-shaped astrocytes: a clinical, neuroradiologic and pathological study of an autopsied case". Neuropathology. 26 (3): 222–30. doi:10.1111/j.1440-1789.2006.00671.x. PMID 16771179. S2CID 25562683.
Priyanka n, Qamar SH, Visanji NP (2024). "Toward an animal model of Progressive Supranuclear Palsy". Frontiers in Neuroscience. 18: 1433465. doi:10.3389/fnins.2024.1433465. ISSN 1662-4548. PMC 11484047. PMID 39420986.
Sonthalia N, Ray S (September 2012). "The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome". BMJ Case Reports. 2012: bcr2012006263. doi:10.1136/bcr-2012-006263. PMC 4543120. PMID 22987902.
Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, et al. (January 1997). "Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study". Brain. 120 (Pt 1): 65–74. doi:10.1093/brain/120.1.65. PMID 9055798.
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. (July 2009). "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury". J Neuropathol Exp Neurol. 68 (7): 709–35. doi:10.1097/NEN.0b013e3181a9d503. PMC 2945234. PMID 19535999.
Ling H (January 2016). "Clinical Approach to Progressive Supranuclear Palsy". Journal of Movement Disorders. 9 (1): 3–13. doi:10.14802/jmd.15060. PMC 4734991. PMID 26828211.
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. (2002). "Guadeloupean parkinsonism: A cluster of progressive supranuclear palsy-like tauopathy". Brain. 125 (4): 801–811. doi:10.1093/brain/awf086. PMID 11912113.
Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (August 2010). "Neuropathology of variants of progressive supranuclear palsy". Current Opinion in Neurology. 23 (4): 394–400. doi:10.1097/WCO.0b013e32833be924. PMID 20610990.
Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T (2013). "Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia". Parkinsonism Relat Disord. 19 (12): 1149–51. doi:10.1016/j.parkreldis.2013.07.019. PMID 23916652.
Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025). "Brainstem and cerebellar radiological findings in progressive supranuclear palsy". Brain Communications. 7 (1): fcaf051. doi:10.1093/braincomms/fcaf051. ISSN 2632-1297. PMC 11829206. PMID 39958262.
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. (July 2017). "Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?". Movement Disorders. 32 (7): 955–971. doi:10.1002/mds.27038. ISSN 0885-3185. PMC 5511762. PMID 28500751.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Moore DP, Puri BK (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience. CRC Press. pp. 400–1. doi:10.1201/b13258. ISBN 978-1-4441-6494-7. OCLC 799764189.
Williams DR, Watt HC, Lees AJ (April 2006). "Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study". Journal of Neurology, Neurosurgery, and Psychiatry. 77 (4): 468–73. doi:10.1136/jnnp.2005.074070. PMC 2077491. PMID 16543524.
Ichikawa-Escamilla E, Velasco-Martínez RA, Adalid-Peralta L (June 2024). "Progressive Supranuclear Palsy Syndrome: An Overview". IBRO Neuroscience Reports. 16: 598–608. doi:10.1016/j.ibneur.2024.04.008. PMC 11126858. PMID 38800085.
Armstrong MJ, Okun MS (2020-02-11). "Diagnosis and Treatment of Parkinson Disease: A Review". JAMA. 323 (6): 548–560. doi:10.1001/jama.2019.22360. ISSN 0098-7484. PMID 32044947.
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. (May 2008). "Clinical outcomes of progressive supranuclear palsy and multiple system atrophy". Brain. 131 (Pt 5): 1362–72. doi:10.1093/brain/awn065. PMID 18385183.
Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. (June 2005). "Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism". Brain. 128 (Pt 6): 1247–58. doi:10.1093/brain/awh488. PMID 15788542.
Williams DR, Lees AJ (March 2009). "Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges". The Lancet. Neurology. 8 (3): 270–9. doi:10.1016/S1474-4422(09)70042-0. PMID 19233037. S2CID 1417930.
Barsottini OG, Felício AC, Aquino CC, Pedroso JL (December 2010). "Progressive supranuclear palsy: new concepts". Arquivos de Neuro-Psiquiatria. 68 (6): 938–46. doi:10.1590/s0004-282x2010000600020. PMID 21243256.
Nijboer H, Dautzenberg PL (June 2009). "[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?]". Tijdschrift voor Gerontologie en Geriatrie. 40 (3): 133–7. doi:10.1007/BF03079574. PMID 19731749. S2CID 140525754.
Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, et al. (January 2010). "Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis". Alzheimer's & Dementia. 6 (1): 70–4. doi:10.1016/j.jalz.2009.04.1231. PMID 20129321. S2CID 33349776.
Abe K (January 2008). "Zolpidem therapy for movement disorders". Recent Patents on CNS Drug Discovery. 3 (1): 55–60. doi:10.2174/157488908783421519. PMID 18221242.
Barsottini OG, Felício AC, Aquino CC, Pedroso JL (December 2010). "Progressive supranuclear palsy: new concepts". Arquivos de Neuro-Psiquiatria. 68 (6): 938–46. doi:10.1590/S0004-282X2010000600020. PMID 21243256.
Zampieri C, Di Fabio RP (June 2006). "Progressive supranuclear palsy: disease profile and rehabilitation strategies". Physical Therapy. 86 (6): 870–80. doi:10.1093/ptj/86.6.870. PMID 16737412.
Sale P, Stocchi F, Galafate D, De Pandis MF, Le Pera D, Sova I, et al. (2014). "Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report". Front Hum Neurosci. 8: 207. doi:10.3389/fnhum.2014.00207. PMC 4029018. PMID 24860459.
van Balken I, Litvan I (May 2006). "Current and future treatments in progressive supranuclear palsy". Current Treatment Options in Neurology. 8 (3): 211–23. doi:10.1007/s11940-006-0012-z. PMID 16569380. S2CID 30537997.
Golbe LI (November 2001). "Progressive Supranuclear Palsy". Current Treatment Options in Neurology. 3 (6): 473–7. doi:10.1007/s11940-001-0010-0. PMID 11581524. S2CID 36973020.
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. (May 2008). "Clinical outcomes of progressive supranuclear palsy and multiple system atrophy". Brain. 131 (Pt 5): 1362–72. doi:10.1093/brain/awn065. PMID 18385183.
Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, et al. (August 13, 2015). "Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study". PLOS ONE. 10 (8): e0135823. Bibcode:2015PLoSO..1035823T. doi:10.1371/journal.pone.0135823. PMC 4536232. PMID 26270456.
Albert ML, Willis A, Feldman RG (1974). "The "subcortical dementias"of progressive supranuclear palsy". Journal of Neurology, Neurosurgery, and Psychiatry. 37 (2): 121–130. doi:10.1136/jnnp.37.2.121. PMC 494589. PMID 4819905.
Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–52. doi:10.1002/mds.10699. PMID 15022178. S2CID 41907329.
Golbe LI (April 2014). "Progressive supranuclear palsy". Seminars in Neurology. 34 (2): 151–9. doi:10.1055/s-0034-1381736. PMID 24963674.
Steele JC, Richardson JC, Olszewski J (April 1964). "Progressive Supranuclear Palsy". Archives of Neurology. 10 (4): 333–59. doi:10.1001/archneur.1964.00460160003001. PMID 14107684.

elsevier.com

linkinghub.elsevier.com

Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, et al. (September 2019). "Four-repeat tauopathies". Progress in Neurobiology. 180: 101644. doi:10.1016/j.pneurobio.2019.101644. PMID 31238088.

harvard.edu

ui.adsabs.harvard.edu

Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, et al. (August 13, 2015). "Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study". PLOS ONE. 10 (8): e0135823. Bibcode:2015PLoSO..1035823T. doi:10.1371/journal.pone.0135823. PMC 4536232. PMID 26270456.

hollywoodreporter.com

Bentley J (May 3, 2020). "'Zoey's Extraordinary Playlist' Boss on That Devastating Finale and Season 2 Plans". The Hollywood Reporter. Retrieved 2020-05-04.

independent.ie

"'I don't want to believe I have an incurable brain disease, but I know I have' - former RTE presenter Kieron Wood". 21 October 2019.

jamanetwork.com

Armstrong MJ, Okun MS (2020-02-11). "Diagnosis and Treatment of Parkinson Disease: A Review". JAMA. 323 (6): 548–560. doi:10.1001/jama.2019.22360. ISSN 0098-7484. PMID 32044947.

medlink.com

Hershey L, Lichter D (10 June 2016). "Progressive supranuclear palsy: cognitive and behavioral changes". MedLink Neurology: 1–37.

metapress.com

cjns.metapress.com

Keith-Rokosh J, Ang LC (November 2008). "Progressive supranuclear palsy: a review of co-existing neurodegeneration". The Canadian Journal of Neurological Sciences. 35 (5): 602–8. doi:10.1017/S0317167100009392. PMID 19235444.

newyorker.com

Schulman M (September 1, 2019). "Linda Ronstadt Has Found Another Voice". The New Yorker.

nhs.uk

"Symptoms - Progressive supranuclear palsy". NHS. 14 August 2018. Retrieved 19 January 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Golbe LI (April 2014). "Progressive supranuclear palsy". Seminars in Neurology. 34 (2): 151–9. doi:10.1055/s-0034-1381736. PMID 24963674.
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (July 2017). "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches". The Lancet Neurology. 16 (7): 552–563. doi:10.1016/S1474-4422(17)30157-6. PMC 5802400. PMID 28653647.
Lopez G, Bayulkem K, Hallett M (October 2016). "Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants". Acta Neurologica Scandinavica. 134 (4): 242–249. doi:10.1111/ane.12546. PMC 7292631. PMID 27070344.
Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: New disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–252. doi:10.1002/mds.10699. ISSN 0885-3185. PMID 15022178.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Finger EC (April 2016). "Frontotemporal Dementias". Continuum. 22 (2 Dementia): 464–89. doi:10.1212/CON.0000000000000300. PMC 5390934. PMID 27042904.
Dunning EE, Decourt B, Zawia NH, Shill HA, Sabbagh MN (August 2024). "Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review". Neurology and Therapy. 13 (4): 975–1013. doi:10.1007/s40120-024-00614-9. ISSN 2193-8253. PMC 11263316. PMID 38743312.
Alexander RG, Macknik SL, Martinez-Conde S (2018). "Microsaccade Characteristics in Neurological and Ophthalmic Disease". Frontiers in Neurology. 9 (144): 144. doi:10.3389/fneur.2018.00144. PMC 5859063. PMID 29593642.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Armstrong MJ (March 2018). "Progressive Supranuclear Palsy: an Update". Current Neurology and Neuroscience Reports. 18 (3): 12. doi:10.1007/s11910-018-0819-5. ISSN 1528-4042. PMID 29455271.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Alster P, Madetko N, Koziorowski D, Friedman A (2020-03-10). "Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)". Frontiers in Neurology. 11: 180. doi:10.3389/fneur.2020.00180. ISSN 1664-2295. PMC 7078665. PMID 32218768.
Chunowski P, Madetko-Alster N, Alster P (2024-09-28). "Asymmetry in Atypical Parkinsonian Syndromes-A Review". Journal of Clinical Medicine. 13 (19): 5798. doi:10.3390/jcm13195798. ISSN 2077-0383. PMC 11477316. PMID 39407856.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, et al. (September 2019). "Four-repeat tauopathies". Progress in Neurobiology. 180: 101644. doi:10.1016/j.pneurobio.2019.101644. PMID 31238088.
Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW (2002). "A clinicopathological study of vascular progressive supranuclear palsy: A multi-infarct disorder presenting as progressive supranuclear palsy". Archives of Neurology. 59 (10): 1597–601. doi:10.1001/archneur.59.10.1597. PMID 12374498.
Wen Y, Zhou Y, Jiao B, Shen L (2021). "Genetics of Progressive Supranuclear Palsy: A Review". Journal of Parkinson's Disease. 11 (1): 93–105. doi:10.3233/JPD-202302. ISSN 1877-718X. PMC 7990399. PMID 33104043.
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. (April 2002). "Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy". Brain. 125 (Pt 4): 801–11. doi:10.1093/brain/awf086. PMID 11912113.
Amano N, Iwabuchi K, Yokoi S, Yagishita S, Itoh Y, Saitoh A, et al. (January 1989). "[The reappraisal study of the ultrastructure of Alzheimer's neurofibrillary tangles in three cases of progressive supranuclear palsy]". No to Shinkei = Brain and Nerve (in Japanese). 41 (1): 35–44. PMID 2655673.
Buée L, Delacourte A (October 1999). "Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease". Brain Pathology. 9 (4): 681–93. doi:10.1111/j.1750-3639.1999.tb00550.x. PMC 8098140. PMID 10517507. S2CID 10711305.
Feany MB, Mattiace LA, Dickson DW (January 1996). "Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration". Journal of Neuropathology and Experimental Neurology. 55 (1): 53–67. doi:10.1097/00005072-199601000-00006. PMID 8558172.
Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (April 2006). "Lewy bodies in progressive supranuclear palsy represent an independent disease process". Journal of Neuropathology and Experimental Neurology. 65 (4): 387–95. doi:10.1097/01.jnen.0000218449.17073.43. PMID 16691119.
Keith-Rokosh J, Ang LC (November 2008). "Progressive supranuclear palsy: a review of co-existing neurodegeneration". The Canadian Journal of Neurological Sciences. 35 (5): 602–8. doi:10.1017/S0317167100009392. PMID 19235444.
Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, et al. (March 2015). "Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology". Movement Disorders Clinical Practice. 2 (1): 33–38. doi:10.1002/mdc3.12104. PMC 6183005. PMID 30363831.
Gearing M, Olson DA, Watts RL, Mirra SS (June 1994). "Progressive supranuclear palsy: neuropathologic and clinical heterogeneity". Neurology. 44 (6): 1015–24. doi:10.1212/wnl.44.6.1015. PMID 8208392. S2CID 20622672.
Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. (Arizona Parkinson's Disease Consortium) (May 2014). "Concomitant pathologies among a spectrum of parkinsonian disorders". Parkinsonism & Related Disorders. 20 (5): 525–9. doi:10.1016/j.parkreldis.2014.02.012. PMC 4028418. PMID 24637124.
Kertesz A, Munoz D (2004). "Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy". Dementia and Geriatric Cognitive Disorders. 17 (4): 282–6. doi:10.1159/000077155. PMID 15178937. S2CID 21017979.
Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, et al. (September 2003). "4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 106 (3): 251–60. doi:10.1007/s00401-003-0728-8. PMID 12802605. S2CID 20275104.
Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, et al. (August 2003). "Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain". Acta Neuropathologica. 106 (2): 143–9. doi:10.1007/s00401-003-0711-4. PMID 12732936. S2CID 25741692.
Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, et al. (October 1998). "Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 96 (4): 401–8. doi:10.1007/s004010050911. PMID 9797005. S2CID 7265831.
Zhu MW, Wang LN, Li XH, Gui QP (April 2004). "[Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration]" [Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration]. Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology (in Chinese). 33 (2): 125–9. doi:10.3760/j.issn:0529-5807.2004.02.008. PMID 15132848.
Wang LN, Zhu MW, Feng YQ, Wang JH (June 2006). "Pick's disease with Pick bodies combined with progressive supranuclear palsy without tuft-shaped astrocytes: a clinical, neuroradiologic and pathological study of an autopsied case". Neuropathology. 26 (3): 222–30. doi:10.1111/j.1440-1789.2006.00671.x. PMID 16771179. S2CID 25562683.
Priyanka n, Qamar SH, Visanji NP (2024). "Toward an animal model of Progressive Supranuclear Palsy". Frontiers in Neuroscience. 18: 1433465. doi:10.3389/fnins.2024.1433465. ISSN 1662-4548. PMC 11484047. PMID 39420986.
Sonthalia N, Ray S (September 2012). "The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome". BMJ Case Reports. 2012: bcr2012006263. doi:10.1136/bcr-2012-006263. PMC 4543120. PMID 22987902.
Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, et al. (January 1997). "Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study". Brain. 120 (Pt 1): 65–74. doi:10.1093/brain/120.1.65. PMID 9055798.
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. (July 2009). "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury". J Neuropathol Exp Neurol. 68 (7): 709–35. doi:10.1097/NEN.0b013e3181a9d503. PMC 2945234. PMID 19535999.
Ling H (January 2016). "Clinical Approach to Progressive Supranuclear Palsy". Journal of Movement Disorders. 9 (1): 3–13. doi:10.14802/jmd.15060. PMC 4734991. PMID 26828211.
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. (2002). "Guadeloupean parkinsonism: A cluster of progressive supranuclear palsy-like tauopathy". Brain. 125 (4): 801–811. doi:10.1093/brain/awf086. PMID 11912113.
Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (August 2010). "Neuropathology of variants of progressive supranuclear palsy". Current Opinion in Neurology. 23 (4): 394–400. doi:10.1097/WCO.0b013e32833be924. PMID 20610990.
Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T (2013). "Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia". Parkinsonism Relat Disord. 19 (12): 1149–51. doi:10.1016/j.parkreldis.2013.07.019. PMID 23916652.
Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025). "Brainstem and cerebellar radiological findings in progressive supranuclear palsy". Brain Communications. 7 (1): fcaf051. doi:10.1093/braincomms/fcaf051. ISSN 2632-1297. PMC 11829206. PMID 39958262.
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. (July 2017). "Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?". Movement Disorders. 32 (7): 955–971. doi:10.1002/mds.27038. ISSN 0885-3185. PMC 5511762. PMID 28500751.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Williams DR, Watt HC, Lees AJ (April 2006). "Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study". Journal of Neurology, Neurosurgery, and Psychiatry. 77 (4): 468–73. doi:10.1136/jnnp.2005.074070. PMC 2077491. PMID 16543524.
Ichikawa-Escamilla E, Velasco-Martínez RA, Adalid-Peralta L (June 2024). "Progressive Supranuclear Palsy Syndrome: An Overview". IBRO Neuroscience Reports. 16: 598–608. doi:10.1016/j.ibneur.2024.04.008. PMC 11126858. PMID 38800085.
Armstrong MJ, Okun MS (2020-02-11). "Diagnosis and Treatment of Parkinson Disease: A Review". JAMA. 323 (6): 548–560. doi:10.1001/jama.2019.22360. ISSN 0098-7484. PMID 32044947.
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. (May 2008). "Clinical outcomes of progressive supranuclear palsy and multiple system atrophy". Brain. 131 (Pt 5): 1362–72. doi:10.1093/brain/awn065. PMID 18385183.
Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. (June 2005). "Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism". Brain. 128 (Pt 6): 1247–58. doi:10.1093/brain/awh488. PMID 15788542.
Williams DR, Lees AJ (March 2009). "Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges". The Lancet. Neurology. 8 (3): 270–9. doi:10.1016/S1474-4422(09)70042-0. PMID 19233037. S2CID 1417930.
Barsottini OG, Felício AC, Aquino CC, Pedroso JL (December 2010). "Progressive supranuclear palsy: new concepts". Arquivos de Neuro-Psiquiatria. 68 (6): 938–46. doi:10.1590/s0004-282x2010000600020. PMID 21243256.
Nijboer H, Dautzenberg PL (June 2009). "[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?]". Tijdschrift voor Gerontologie en Geriatrie. 40 (3): 133–7. doi:10.1007/BF03079574. PMID 19731749. S2CID 140525754.
Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, et al. (January 2010). "Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis". Alzheimer's & Dementia. 6 (1): 70–4. doi:10.1016/j.jalz.2009.04.1231. PMID 20129321. S2CID 33349776.
Abe K (January 2008). "Zolpidem therapy for movement disorders". Recent Patents on CNS Drug Discovery. 3 (1): 55–60. doi:10.2174/157488908783421519. PMID 18221242.
Barsottini OG, Felício AC, Aquino CC, Pedroso JL (December 2010). "Progressive supranuclear palsy: new concepts". Arquivos de Neuro-Psiquiatria. 68 (6): 938–46. doi:10.1590/S0004-282X2010000600020. PMID 21243256.
Zampieri C, Di Fabio RP (June 2006). "Progressive supranuclear palsy: disease profile and rehabilitation strategies". Physical Therapy. 86 (6): 870–80. doi:10.1093/ptj/86.6.870. PMID 16737412.
Sale P, Stocchi F, Galafate D, De Pandis MF, Le Pera D, Sova I, et al. (2014). "Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report". Front Hum Neurosci. 8: 207. doi:10.3389/fnhum.2014.00207. PMC 4029018. PMID 24860459.
van Balken I, Litvan I (May 2006). "Current and future treatments in progressive supranuclear palsy". Current Treatment Options in Neurology. 8 (3): 211–23. doi:10.1007/s11940-006-0012-z. PMID 16569380. S2CID 30537997.
Golbe LI (November 2001). "Progressive Supranuclear Palsy". Current Treatment Options in Neurology. 3 (6): 473–7. doi:10.1007/s11940-001-0010-0. PMID 11581524. S2CID 36973020.
O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. (May 2008). "Clinical outcomes of progressive supranuclear palsy and multiple system atrophy". Brain. 131 (Pt 5): 1362–72. doi:10.1093/brain/awn065. PMID 18385183.
Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, et al. (August 13, 2015). "Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study". PLOS ONE. 10 (8): e0135823. Bibcode:2015PLoSO..1035823T. doi:10.1371/journal.pone.0135823. PMC 4536232. PMID 26270456.
Albert ML, Willis A, Feldman RG (1974). "The "subcortical dementias"of progressive supranuclear palsy". Journal of Neurology, Neurosurgery, and Psychiatry. 37 (2): 121–130. doi:10.1136/jnnp.37.2.121. PMC 494589. PMID 4819905.
Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–52. doi:10.1002/mds.10699. PMID 15022178. S2CID 41907329.
Golbe LI (April 2014). "Progressive supranuclear palsy". Seminars in Neurology. 34 (2): 151–9. doi:10.1055/s-0034-1381736. PMID 24963674.
Richardson JC, Steele J, Olszewski J (1963). "Supranuclear Ophthalmoplegia, Pseudobulbar Palsy, Nuchal Dystonia and Dementia. A Clinical Report on Eight Cases of 'heterogenous System Degeneration'". Transactions of the American Neurological Association. 88: 25–9. PMID 14272249.
Steele JC, Richardson JC, Olszewski J (April 1964). "Progressive Supranuclear Palsy". Archives of Neurology. 10 (4): 333–59. doi:10.1001/archneur.1964.00460160003001. PMID 14107684.

ncbi.nlm.nih.gov

Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (July 2017). "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches". The Lancet Neurology. 16 (7): 552–563. doi:10.1016/S1474-4422(17)30157-6. PMC 5802400. PMID 28653647.
Lopez G, Bayulkem K, Hallett M (October 2016). "Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants". Acta Neurologica Scandinavica. 134 (4): 242–249. doi:10.1111/ane.12546. PMC 7292631. PMID 27070344.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Finger EC (April 2016). "Frontotemporal Dementias". Continuum. 22 (2 Dementia): 464–89. doi:10.1212/CON.0000000000000300. PMC 5390934. PMID 27042904.
Dunning EE, Decourt B, Zawia NH, Shill HA, Sabbagh MN (August 2024). "Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review". Neurology and Therapy. 13 (4): 975–1013. doi:10.1007/s40120-024-00614-9. ISSN 2193-8253. PMC 11263316. PMID 38743312.
Alexander RG, Macknik SL, Martinez-Conde S (2018). "Microsaccade Characteristics in Neurological and Ophthalmic Disease". Frontiers in Neurology. 9 (144): 144. doi:10.3389/fneur.2018.00144. PMC 5859063. PMID 29593642.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Coughlin DG, Litvan I (April 2020). "Progressive supranuclear palsy: Advances in diagnosis and management". Parkinsonism & Related Disorders. 73: 105–116. doi:10.1016/j.parkreldis.2020.04.014. PMC 7462164. PMID 32487421.
Alster P, Madetko N, Koziorowski D, Friedman A (2020-03-10). "Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)". Frontiers in Neurology. 11: 180. doi:10.3389/fneur.2020.00180. ISSN 1664-2295. PMC 7078665. PMID 32218768.
Chunowski P, Madetko-Alster N, Alster P (2024-09-28). "Asymmetry in Atypical Parkinsonian Syndromes-A Review". Journal of Clinical Medicine. 13 (19): 5798. doi:10.3390/jcm13195798. ISSN 2077-0383. PMC 11477316. PMID 39407856.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Wen Y, Zhou Y, Jiao B, Shen L (2021). "Genetics of Progressive Supranuclear Palsy: A Review". Journal of Parkinson's Disease. 11 (1): 93–105. doi:10.3233/JPD-202302. ISSN 1877-718X. PMC 7990399. PMID 33104043.
Buée L, Delacourte A (October 1999). "Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease". Brain Pathology. 9 (4): 681–93. doi:10.1111/j.1750-3639.1999.tb00550.x. PMC 8098140. PMID 10517507. S2CID 10711305.
Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, et al. (March 2015). "Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology". Movement Disorders Clinical Practice. 2 (1): 33–38. doi:10.1002/mdc3.12104. PMC 6183005. PMID 30363831.
Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. (Arizona Parkinson's Disease Consortium) (May 2014). "Concomitant pathologies among a spectrum of parkinsonian disorders". Parkinsonism & Related Disorders. 20 (5): 525–9. doi:10.1016/j.parkreldis.2014.02.012. PMC 4028418. PMID 24637124.
Priyanka n, Qamar SH, Visanji NP (2024). "Toward an animal model of Progressive Supranuclear Palsy". Frontiers in Neuroscience. 18: 1433465. doi:10.3389/fnins.2024.1433465. ISSN 1662-4548. PMC 11484047. PMID 39420986.
Sonthalia N, Ray S (September 2012). "The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome". BMJ Case Reports. 2012: bcr2012006263. doi:10.1136/bcr-2012-006263. PMC 4543120. PMID 22987902.
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. (July 2009). "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury". J Neuropathol Exp Neurol. 68 (7): 709–35. doi:10.1097/NEN.0b013e3181a9d503. PMC 2945234. PMID 19535999.
Ling H (January 2016). "Clinical Approach to Progressive Supranuclear Palsy". Journal of Movement Disorders. 9 (1): 3–13. doi:10.14802/jmd.15060. PMC 4734991. PMID 26828211.
Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025). "Brainstem and cerebellar radiological findings in progressive supranuclear palsy". Brain Communications. 7 (1): fcaf051. doi:10.1093/braincomms/fcaf051. ISSN 2632-1297. PMC 11829206. PMID 39958262.
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. (July 2017). "Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?". Movement Disorders. 32 (7): 955–971. doi:10.1002/mds.27038. ISSN 0885-3185. PMC 5511762. PMID 28500751.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Williams DR, Watt HC, Lees AJ (April 2006). "Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study". Journal of Neurology, Neurosurgery, and Psychiatry. 77 (4): 468–73. doi:10.1136/jnnp.2005.074070. PMC 2077491. PMID 16543524.
Ichikawa-Escamilla E, Velasco-Martínez RA, Adalid-Peralta L (June 2024). "Progressive Supranuclear Palsy Syndrome: An Overview". IBRO Neuroscience Reports. 16: 598–608. doi:10.1016/j.ibneur.2024.04.008. PMC 11126858. PMID 38800085.
Sale P, Stocchi F, Galafate D, De Pandis MF, Le Pera D, Sova I, et al. (2014). "Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report". Front Hum Neurosci. 8: 207. doi:10.3389/fnhum.2014.00207. PMC 4029018. PMID 24860459.
Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, et al. (August 13, 2015). "Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study". PLOS ONE. 10 (8): e0135823. Bibcode:2015PLoSO..1035823T. doi:10.1371/journal.pone.0135823. PMC 4536232. PMID 26270456.
Albert ML, Willis A, Feldman RG (1974). "The "subcortical dementias"of progressive supranuclear palsy". Journal of Neurology, Neurosurgery, and Psychiatry. 37 (2): 121–130. doi:10.1136/jnnp.37.2.121. PMC 494589. PMID 4819905.

ninds.nih.gov

"Progressive Supranuclear Palsy Fact Sheet". National Institute of Neurological Disorders and Stroke. Retrieved 19 February 2019.

omim.org

Online Mendelian Inheritance in Man (OMIM): Supranuclear Palsy, Progressive, 1; PSNP1 - 601104

orpha.net

"Orphanet: Progressive supranuclear palsy". Orpha.net. Retrieved 2017-01-08.

oup.com

academic.oup.com

Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. (2002). "Guadeloupean parkinsonism: A cluster of progressive supranuclear palsy-like tauopathy". Brain. 125 (4): 801–811. doi:10.1093/brain/awf086. PMID 11912113.

psp.org

CurePSP, re-linked 2020-01-20

pspaireland.ie

"What is PSP". 18 October 2013.

pspassociation.org.uk

PSPA, re-linked 2020-01-20

pspawareness.com

"Progressive Supranuclear Palsy". CCF for PSP Awareness. Retrieved 2023-07-11.

pspfrance.org

PSP France - Notre histoire, re-linked 2020-01-20

pspsocietycanada.ca

PSP Society of Canada, re-linked 2020-01-20

rarediseases.org

"Progressive Supranuclear Palsy". NORD (National Organization for Rare Disorders). Retrieved 2022-03-18.
Elble RJ. "Progressive Supranuclear Palsy". www.rarediseases.org.
"Progressive Supranuclear Palsy – NORD (National Organization for Rare Disorders)". Rarediseases.org. Retrieved 2017-01-08.

semanticscholar.org

api.semanticscholar.org

Buée L, Delacourte A (October 1999). "Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease". Brain Pathology. 9 (4): 681–93. doi:10.1111/j.1750-3639.1999.tb00550.x. PMC 8098140. PMID 10517507. S2CID 10711305.
Gearing M, Olson DA, Watts RL, Mirra SS (June 1994). "Progressive supranuclear palsy: neuropathologic and clinical heterogeneity". Neurology. 44 (6): 1015–24. doi:10.1212/wnl.44.6.1015. PMID 8208392. S2CID 20622672.
Kertesz A, Munoz D (2004). "Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy". Dementia and Geriatric Cognitive Disorders. 17 (4): 282–6. doi:10.1159/000077155. PMID 15178937. S2CID 21017979.
Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, et al. (September 2003). "4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 106 (3): 251–60. doi:10.1007/s00401-003-0728-8. PMID 12802605. S2CID 20275104.
Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, et al. (August 2003). "Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain". Acta Neuropathologica. 106 (2): 143–9. doi:10.1007/s00401-003-0711-4. PMID 12732936. S2CID 25741692.
Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, et al. (October 1998). "Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy". Acta Neuropathologica. 96 (4): 401–8. doi:10.1007/s004010050911. PMID 9797005. S2CID 7265831.
Wang LN, Zhu MW, Feng YQ, Wang JH (June 2006). "Pick's disease with Pick bodies combined with progressive supranuclear palsy without tuft-shaped astrocytes: a clinical, neuroradiologic and pathological study of an autopsied case". Neuropathology. 26 (3): 222–30. doi:10.1111/j.1440-1789.2006.00671.x. PMID 16771179. S2CID 25562683.
Williams DR, Lees AJ (March 2009). "Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges". The Lancet. Neurology. 8 (3): 270–9. doi:10.1016/S1474-4422(09)70042-0. PMID 19233037. S2CID 1417930.
Nijboer H, Dautzenberg PL (June 2009). "[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?]". Tijdschrift voor Gerontologie en Geriatrie. 40 (3): 133–7. doi:10.1007/BF03079574. PMID 19731749. S2CID 140525754.
Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, et al. (January 2010). "Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis". Alzheimer's & Dementia. 6 (1): 70–4. doi:10.1016/j.jalz.2009.04.1231. PMID 20129321. S2CID 33349776.
van Balken I, Litvan I (May 2006). "Current and future treatments in progressive supranuclear palsy". Current Treatment Options in Neurology. 8 (3): 211–23. doi:10.1007/s11940-006-0012-z. PMID 16569380. S2CID 30537997.
Golbe LI (November 2001). "Progressive Supranuclear Palsy". Current Treatment Options in Neurology. 3 (6): 473–7. doi:10.1007/s11940-001-0010-0. PMID 11581524. S2CID 36973020.
Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–52. doi:10.1002/mds.10699. PMID 15022178. S2CID 41907329.

springer.com

link.springer.com

Armstrong MJ (March 2018). "Progressive Supranuclear Palsy: an Update". Current Neurology and Neuroscience Reports. 18 (3): 12. doi:10.1007/s11910-018-0819-5. ISSN 1528-4042. PMID 29455271.

straitstimes.com

Tham YC, Mujibah F (2024-10-09). "Lee Wei Ling, Lee Kuan Yew's daughter, dies at 69". The Straits Times. ISSN 0585-3923. Retrieved 2024-10-09.

washingtonpost.com

Portnoy J (18 September 2023). "Rep. Jennifer Wexton will not seek reelection as diagnosis changes". Washington Post.

web.archive.org

"What's New in Progressive Supranuclear Palsy?" (PDF). Acnr.org. Archived from the original (PDF) on 2016-09-09. Retrieved 2017-01-08.

who.int

icd.who.int

"ICD-11 - Mortality and Morbidity Statistics". icd.who.int.

wiley.com

movementdisorders.onlinelibrary.wiley.com

Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: New disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–252. doi:10.1002/mds.10699. ISSN 0885-3185. PMID 15022178.

worldcat.org

search.worldcat.org

Brusa A, Stoehr R, Pramstaller PP (March 2004). "Progressive supranuclear palsy: New disease or variant of postencephalitic parkinsonism?". Movement Disorders. 19 (3): 247–252. doi:10.1002/mds.10699. ISSN 0885-3185. PMID 15022178.
Dunning EE, Decourt B, Zawia NH, Shill HA, Sabbagh MN (August 2024). "Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review". Neurology and Therapy. 13 (4): 975–1013. doi:10.1007/s40120-024-00614-9. ISSN 2193-8253. PMC 11263316. PMID 38743312.
Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL (2016). Bradley's neurology in clinical practice. Vol. 2 (7th ed.). Elsevier. p. 1439. ISBN 978-0-323-28783-8. OCLC 932031625.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Armstrong MJ (March 2018). "Progressive Supranuclear Palsy: an Update". Current Neurology and Neuroscience Reports. 18 (3): 12. doi:10.1007/s11910-018-0819-5. ISSN 1528-4042. PMID 29455271.
Alster P, Madetko N, Koziorowski D, Friedman A (2020-03-10). "Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)". Frontiers in Neurology. 11: 180. doi:10.3389/fneur.2020.00180. ISSN 1664-2295. PMC 7078665. PMID 32218768.
Chunowski P, Madetko-Alster N, Alster P (2024-09-28). "Asymmetry in Atypical Parkinsonian Syndromes-A Review". Journal of Clinical Medicine. 13 (19): 5798. doi:10.3390/jcm13195798. ISSN 2077-0383. PMC 11477316. PMID 39407856.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Wen Y, Zhou Y, Jiao B, Shen L (2021). "Genetics of Progressive Supranuclear Palsy: A Review". Journal of Parkinson's Disease. 11 (1): 93–105. doi:10.3233/JPD-202302. ISSN 1877-718X. PMC 7990399. PMID 33104043.
Priyanka n, Qamar SH, Visanji NP (2024). "Toward an animal model of Progressive Supranuclear Palsy". Frontiers in Neuroscience. 18: 1433465. doi:10.3389/fnins.2024.1433465. ISSN 1662-4548. PMC 11484047. PMID 39420986.
Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025). "Brainstem and cerebellar radiological findings in progressive supranuclear palsy". Brain Communications. 7 (1): fcaf051. doi:10.1093/braincomms/fcaf051. ISSN 2632-1297. PMC 11829206. PMID 39958262.
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. (July 2017). "Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?". Movement Disorders. 32 (7): 955–971. doi:10.1002/mds.27038. ISSN 0885-3185. PMC 5511762. PMID 28500751.
Krzosek P, Madetko N, Migda A, Migda B, Jaguś D, Alster P (2022-02-09). "Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism". Frontiers in Aging Neuroscience. 14. doi:10.3389/fnagi.2022.804385. ISSN 1663-4365. PMC 8864174. PMID 35221993.
Moore DP, Puri BK (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience. CRC Press. pp. 400–1. doi:10.1201/b13258. ISBN 978-1-4441-6494-7. OCLC 799764189.
Armstrong MJ, Okun MS (2020-02-11). "Diagnosis and Treatment of Parkinson Disease: A Review". JAMA. 323 (6): 548–560. doi:10.1001/jama.2019.22360. ISSN 0098-7484. PMID 32044947.
Tham YC, Mujibah F (2024-10-09). "Lee Wei Ling, Lee Kuan Yew's daughter, dies at 69". The Straits Times. ISSN 0585-3923. Retrieved 2024-10-09.